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Background: It is largely accepted that specific immunological parameters in solid malignancies are associated
with patient’s prognosis. Recently a correlation of macrophage polarization with histomorphological parameters
could also be shown in oral squamous cell carcinoma (oscc). The observed tumor derived peripheral immune
tolerance could be associated with the macrophage polarization in regional tumor draining lymph nodes.
So far there are no studies analyzing the macrophage polarization in cervical lymph nodes of oscc patients. In the
present study we aimed to correlate macrophage polarization in different anatomical lymph node compartments of
patients diagnosed with oscc with histopathologic parameters of the primary tumor (T-, N-, L-, V-, Pn-status, grading).
Methods: Tumor free (n = 37) and metastatic (n = 17) lymph nodes of T1 and T2 oscc patients were processed for
immunohistochemistry to detect CD68, CD11c, CD163 and MRC1 positive cells. Samples were digitized using whole
slide imaging and the number of cells expressing the aforementioned markers in the region of interest quantitatively
analyzed.
Results: The malignancy of the primary tumor (defined by T-, L-, Pn-status, grading) correlated with the lymph node
macrophage polarization. L1 and Pn1 tumor cases displayed a significantly (p < 0.05) decreased M1 and increased M2
polarization in the sinus of the lymph nodes. G3 cases presented a significantly (p < 0.05) increased M2 polarization in
the sinus compared to G2 cases. T2 tumors had significantly (p < 0.05) increased M2 polarization in the interfollicular
zone of regional lymph nodes compared to T1 tumors. Metastatic and non-metastatic lymph nodes did not differ
regarding their macrophage polarization.
Conclusions: The current study revealed for the first time an influence of oscc on the macrophage polarization in
regional lymph nodes. Markers of malignant behavior in the primary tumor were associated with a shift of macrophage
polarization in lymph nodes from the anti-tumoral M1 type to the tumor-promoting M2 type. As tumor free and
metastatic lymph nodes did not differ in terms of their macrophage polarization pattern, there must be other
factors influencing the location for lymph node metastasis formation.
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Despite the decline in prevalence of smoking in industrial
countries, there is no reduction in oral squamous cell car-
cinoma (oscc) incidence noticeable [1]. It is currently the
8th most frequent tumor worldwide [1-3]. Although, now-
adays there are advances in surgical treatment options, the
overall prognosis of this specific cancer type could not be
improved during the last 30 years [4]. The occurrence of
local lymphogenic metastasis is one of the strongest prog-
nostic determinants in oscc [5,6]. In many cases, oral can-
cer is diagnosed at a metastatic stage causing therapeutic
difficulties [1,7].
The influence of immunological parameters on the
prognosis of oscc has already been discussed in the
1970th and 1980th [8,9]. The non-specific immune param-
eter phytohemagglutinin (PHA) –reactivity, measured in
patient’s serum, showed a significant correlation with the
occurrence of lymph node metastasis [8]. The lymphokine
release measured after mitogenic PHA stimulation is an
indicator for the degree of cellular immune reactivity [8].
Low PHA-reactivity is associated with the tolerance indu-
cing M2 macrophage polarization [10]. In the further
course, immunological contributes to oscc pathogenesis
have been neglected.
Nowadays, literature is conclusive about the fact that
tumor immunology plays an important role for local
lymph node metastasis [11-13]. In our current under-
standing of the formation of lymphogenic metastases,
the concept of peripheral tolerance plays an important
role. The capacity of malignancies to evade host immune
defense reactions and to establish a state of peripheral
immune tolerance was initially described in highly im-
munogenic tumors like melanomas [14,15]. It was shown
that early stage melanomas have the peculiarity to com-
municate with tumor draining lymph nodes and thus pre-
pare them for the acceptance and growth of metastases
[14]. In metastatic lymph nodes there is an immediate
proximity between tumor cells and various types of leuko-
cytes. However, instead of an anti-tumoral immunity, a
state of peripheral immune tolerance can be observed
[14,16]. Besides malignant melanoma, the relevance of im-
munological markers in tumor tissue could be shown in
solid malignancies [11,17-19]. Several studies also demon-
strated the importance of the immune system for oscc
progression [10,17,20-25].
Results of our group reveal a correlation of macro-
phage polarization in oscc specimens with histomorpho-
logical parameters. An increased M2 polarization in the
epithelial tumor compartment was associated with the
occurrence of lymph node metastasis [26].
The human papilloma virus (HPV) associated oscc un-
derlines the importance of the immune system for the
pathogenesis of oral cancer. It is assumed that the favor-
able prognosis in HPV positive cases might be associatedwith an immune response against viral antigens [25,27,28].
This observation outlines the potential ability of the im-
mune system to engage oral cancer.
The lymph flow from tumors is increased compared to
normal tissue [16]. Immune tolerance in regional lymph
nodes is a prerequisite for the formation of lymph node
metastasis [14]. Macrophages and dendritic cells migrate
from peripheral tissue to the lymph nodes and orches-
trate the balance between tolerance and immunity [16].
M1 macrophages are responsible for elimination of path-
ogens, tissue destruction and tumor resistance [29-31].
In contrast, M2 cells have immunoregulatory properties
and are associated with tissue remodeling, angiogenesis
and tumor progression [11,29-34].
CD68 is the best established generic macrophage marker
[11,24,35,36]. M1 macrophages are commonly identified
by staining the CD11c antigen [32,35,37,38], M2 macro-
phages express the antigens CD163 [33,36,39,40] and
MRC1 [32,39,41].
Additionally, the relative proportion of the M1 and
M2 markers should also be considered. In analogy to
other recent studies dealing with macrophage polarization
in human cancer tissues [19,26,42,43], we aimed to
analyze the ratios between the stained markers.
So far no studies exist quantifying the macrophage
polarization in regional tumor draining lymph nodes of
solid malignancies. Therefore, the aim of this study is to
clarify if the macrophage polarization in regional lymph
nodes and lymph node metastases of small (pT1, pT2)
primary oscc is correlated with histopathologic parameters
like TNM-status, grading, lymph-vessel-, and perineural-
infiltration. To this extend immunohistochemical analysis
of the specimens was performed in different lymph node
compartments (interfollicular zone, lymph node sinus and
perisinusoidal zone) using a computer assisted quantita-
tive cell counter.
Methods
Patients and tissue harvesting
Resected lymph nodes of 37 patients, histologically diag-
nosed with primary oscc, were analyzed in this study. 18
patients had proven lymph node metastasis (pN+), 19
were free of metastases (pN0). Metastasis free lymph
nodes were evaluated in each subject no matter of the
lymph node status. Additionally, a positive lymph node
in each pN + case was analyzed. Thus, a total of 54
lymph nodes were examined (17 with and 37 without
metastasis). All included patients were treated in 2011 at
the Department of Oral and Maxillofacial Surgery of the
University Hospital Erlangen. The study protocol was
approved by the ethical committee of the University of
Erlangen-Nuremberg (Ref.-No. 45_12 Bc). The speci-
mens used in this retrospective study were obtained
from tissue samples of consecutive patients collected for
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archival samples from the Comprehensive Cancer Center
Erlangen-EMN. Each included lymph node was judged as
a representative lymph node. Besides the main diagnosis
of oscc following additional inclusion criteria were de-
fined: pT1 and pT2 tumors, no restrictions in the grading
of the tumor, no adjuvant preoperative radio- or chemo-
therapy and no organ metastasis at the time of diagnosis.
Tumor status (T-, N-, L-, Pn-status) and tumor grading
was determined by the routine pathological analysis of the
resected tumor and lymph node specimens.
Only oscc lymph nodes of patients with pT1 and pT2
were considered, because the tumors of these patients are
characterized by a better resectability and prognosis com-
pared to larger pT3 and pT4 tumors [44]. Furthermore, T4
tumors might have a special immunological microenviron-
ment due to their direct contact to bone marrow stem cells.
Patients with former radio- or chemotherapy as well
as pT3 and pT4 tumors were excluded. There were no
study related changes in patient’s treatments.
In terms of the primary tumor location patient collective
(n = 37) consisted of 9 patients with a tumor of the tongue,
15 patients with a tumor of the floor of the mouth, 8 of
the alveolar crest, 3 of the palate and 2 of the cheek.
The average age of the patients (24 males and 13 fe-
males) was 62 years. The pathohistological classified T-,
N-, L-, Pn-status was T1 in 17 cases and T2 in 20 cases,
N0 in 19 cases and N + in 18 cases, L0 in 26 cases and L1
in 10 cases and Pn0 in 23 cases and Pn1 in 10 cases. Some
cases could not be clearly classified regarding their L- and
Pn-status. One case was graded as G1, 28 as G2 and 8 as
G3.
Immunohistochemical stainings
The formalin-fixed, paraffin-embedded tissue samples
were sliced in consecutive sections of 2 μm thickness with
a rotation microtome (Leica, Nussloch, Germany), then
dewaxed in xylole and rehydrated in graded propanol
prior to immunohistochemical staining. Immunohisto-
chemical staining was performed with the LSAB (labeled
streptavidin-biotin) method and an automated staining
device (Autostainer plus, Dako Cytomation, Hamburg,
Germany). The staining kit (Dako Real, Cat. K5001, Dako
Cytomation) was used according to manufacturer’s in-
structions. Proteins were detected by incubating tissues in
the autostainer (21°C, 30 min) with specific antibodies.
The following primary antibodies were used: anti-CD11c
(ab52632, clone EP1347y, Abcam, Cambridge, UK), anti-
CD68 (11081401, clone KP1, Dako, Hamburg, Germany),
anti-CD163 (MAB1652, clone K20-T, Abnova, Taipei City,
Taiwan) and anti-MRC1 (H00004360-1102, clone 5C11,
Abnova).
As secondary antibody the biotinylated immunoglob-
ulins were used for all samples. Stained portions werevisualized with the DAB + solution (Dako Cytomation),
localized by biotin-associated activation of the second-
ary antibodies. This was followed by incubation in
hematoxylin (Dako Cytomation) for counterstaining of
the nucleus. Two consecutive tissue samples were proc-
essed per immunohistochemical staining; one served as
a negative control in each case (identical treatment, but
replacement of the primary antibody with an IgG-
isotype of the primary antibody). A positive control
sample that was known to stain positive for a given anti-
body was included in each series.Quantitative immunohistochemical analysis
The lymph node sections were completely scanned and
digitized using the method of “whole slide imaging”. The
scanning procedure was performed in cooperation with the
Institute of Pathology of the University of Erlangen using a
Zeiss MIRAX MIDI Scanner (Zeiss, Jena, Germany). All
samples were analyzed on a computer (Panoramic MIRAX
viewer, Zeiss, Jena, Germany). Quality controls were per-
formed under a bright-field microscope (Zeiss Axioskop
and Axiocam 5, at 100–400 ×magnification). HE-stained
sections of all samples were examined by a pathologist to
ensure that all samples contained representative lymph
nodes.
For each sample, the following two different categories
of visual fields were selected: The lymph node sinus and
the interfollicular zone (Figure 1). For each category,
three visual fields per section showing the highest infil-
tration rate of CD68 expressing cells were selected. For
the other markers (CD11c, CD163 and MRC1) the cor-
responding fields of view were selected (Figure 1) using
multi-monitor virtual microscopy (Panoramic MIRAX
viewer, Zeiss). Consequently, 24 fields of view were
assessed for cell counting for each specimen.
The complete area of all three visual fields of one cat-
egory was between 1.1 mm2 and 1.5 mm2.
The images showing the visual fields were imported
into Biomas (MSAB, Erlangen, Germany) for cell count-
ing. In the visual fields of the sinuses two regions of
interest were defined in Biomas software: The perisinu-
soidal zone and the lymph node sinus (LN sinus).
A quantitative analysis was performed to determine the
infiltration levels of CD11c-, CD68-, CD163- and MRC1-
positive cells in the lymph node sinus (LN sinus), the peri-
sinusoidal zone and the interfollicular zone (LN IFZ). All
positive cells in the aforementioned compartments were
manually counted. Cell density per mm2 was automatic-
ally calculated by the Biomas software. Only cells with a
monocytoid/macrophage-like morphology were counted.
Cell counting was performed in a blinded manner by re-
search fellows familiar with tissue morphology analyses
and immunohistochemical methods.
Figure 1 Selection of corresponding fields of view in a lymph node metastasis. The figure shows exemplarily two sequential slides of a
lymph node metastasis specimen virtually microscoped. On the left side CD68 positive cells and on the right side MRC1 positive cells are stained.
Visual fields for cell count are shown: lymph node sinus (LN sinus) - yellow, lymph node interfollicular zone (LN IFZ) - blue, metastatic tumor
(TU) - red, tumor invasion front (TU Front) - green. Corresponding fields of view have been selected for LN sinus, LN IFZ and TU Front. In TU fields
of view for each marker the region of the highest expression was selected.
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In order to analyze immunohistochemical staining and
spatial expression patterns, the cell count per mm2 was
determined as the number of positive cells per mm2 of
the specimen. Multiple measurements were pooled for
each sample group prior to analysis. The results are
expressed as the median, the interquartile range (IQR),
standard deviation (SD) and range. Box plot diagrams
represent the median, the interquartile range, minimum
(Min) and maximum (Max).
Two-sided, adjusted p-values ≤ 0.05 were considered
to be significant. Analyses were performed with SPSS 21
for Mac OS (IBM Inc, New York, USA).
Results
General morphological considerations
All specimens were analyzed in a virtual microscope sys-
tem. Except for CD11c, all stained markers displayed a sig-
nificantly (p < 0.001) higher number of positive cells in the
lymph node sinus compared to the other analyzed com-
partments. In the sinus, the distribution of macrophagesseemed to be quite homogeneous. In the interfollicular
zone some spots of increased infiltration were visible.
CD68 staining was used to define the visual field sub-
sequently analyzed for all stainings (Figure 1). CD68
positive cells could be identified in all lymph node com-
partments including the follicles. A cytoplasmatic expres-
sion was found. The shape of the stained cells included
predominantly round cells, but some cells also showed a
spindle-shape (Figure 2). CD11c expressing M1 macro-
phages were found in all lymph node compartments. The
distribution pattern of the CD11c expressing cells was
more comparable to CD68 positive cells than to the distri-
bution of M2 marker expressing cells. Compared to the
other analyzed compartments there was no significant ac-
cumulation of CD11c expressing cells in the lymph node
sinus. The CD11c expressing cells were stained cytoplas-
matically as well as membrane-bound and had a round
shape (Figure 2). The M2 markers CD163 and MRC1
showed an accentuation of expression in the lymph node
sinus. In contrast to CD68 and CD11c, in the follicles no
expression of the M2 markers was detectable. CD163 and
a b
dc
Figure 2 Typical expression pattern of the macrophage markers CD68, CD11c, CD163 and MRC1 in a lymph node. Exemplary fields of
view (original magnification 40x) showing the typical expression pattern of the stained macrophage markers CD68, CD11c, CD163 and MRC1 in
lymph node specimens. a) CD68: The marker shows a cytoplasmatic staining. The shape of the stained cells includes predominantly round cells,
but some cells also show a spindle-shape. CD68 is expressed in the follicles, in the interfollicular zone and in the sinus. Besides a distinct staining
of the macrophages, in lymph node metastasis specimens a pale staining of tumor cells was also detectable. b) CD11c: The marker shows a
cytoplasmatic expression pattern with an accentuation of the plasma membrane. The shape of the stained cells includes predominantly round
cells. CD11c expressing cells were mainly found in the follicles and in the interfollicular zone. c) CD163: The marker shows a cytoplasmatic
expression pattern with an accentuation of the plasma membrane. The shape of the stained cells includes predominantly spindle-shaped cells.
CD163 expression can predominantly be found in the lymph node sinus. The follicles are largely missing CD163 expressing cells. d) MRC1:
The marker shows a cytoplasmatic expression pattern with an accentuation of the plasma membrane. The shape of the stained cells includes
predominantly spindle-shaped cells. MRC1 expression can predominantly be found in the lymph node sinus. The follicles are largely missing
MRC1 expressing cells.
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membrane-bound. Most of the stained cells had a
spindle-shape (Figure 2).Macrophage polarization and lymph node metastasis
Comparing the macrophage polarization in the tumor
free lymph nodes and in the metastatic nodes, no statis-
tical significant differences could be detected. There was
also no tendency of any parameter to be different be-
tween the groups. This finding supports the hypothesis
that metastatic and non-metastatic lymph nodes do not
differ regarding their macrophage polarization.Macrophage polarization and the N-status
Macrophage polarizations in tumor free lymph nodes of
patients with nodal metastases (pN+) were compared to
patients without lymph node metastases (pN0). No cor-
relation of the macrophage polarization in tumor free
lymph nodes with the pN-status was observed.Macrophage polarization and the L-status
A correlation of the macrophage polarization in tumor
free regional lymph nodes with histologically defined
lymph vessel infiltration status (L-status) of the primary
tumor could be identified. The ratio between the CD11c
positive cells (predominantly M1 macrophages) and CD68
positive cells (all macrophages) represents the degree of
M1 polarization. In the lymph node sinus (LN sinus) the
CD11c/CD68 ratio was significantly (p = 0.015) lower in
the L1 cases (median value 0.20) compared to L0 cases
(median value 0.44) (Table 1, Figure 3a).
The degree of M2 polarization can be described by the
ratio of M2 markers CD163 or MRC1 and CD11c. In the
LN sinus the CD163/CD11c ratio was significantly (p =
0.001) higher in the L1 cases (median value of 5.01) than
in the L0 cases (median value of 2.78) (Table 1, Figure 3b).
A similar proportion was revealed by the MRC1/CD11c
ratio. With a median value of 17.73 there was a signifi-
cantly (p = 0.001) higher ratio in L1 cases compared to L0
cases with a median value of 7.19 (Table 1, Figure 3c).
Table 1 Ratio of macrophage marker expression depending on the T-status, N-status, L-status, Pn-status and grading















Median SD Median SD Median SD Median SD Median SD Median SD Median SD
T-status n
T1 17 0.33 0.23 1.09 0.63 4.03 1.72 3.81 2.39 10.07 11.57 0.33 0.19 0.36 0.21
T2 19 0.39 0.36 0.99 0.38 3.36 1.55 3.25 2.81 8.76 8.56 0.6 0.29 0.51 0.4
p-value 0.455 0.464 0.384 0.608 0.328 0.027 0.041
N-status n
N0 19 0.33 0.25 1.08 0.58 3.39 1.92 3.66 2.23 12.46 8.60 0.32 0.24 0.36 0.39
N+ 17 0.36 0.36 1.02 0.43 3.65 1.25 3.11 3.00 7.39 11.78 0.60 0.27 0.49 0.29
p-value 0.902 0.963 0.458 0.725 0.958 0.073 0.922
L-status n
L0 26 0.44 0.32 0.99 0.60 3.36 1.67 2.78 1.6 7.19 5.24 0.45 0.25 0.49 0.36
L1 10 0.2 0.14 1.09 0.17 3.52 0.93 5.01 3.35 17.73 13.36 0.35 0.30 0.33 0.28
p-value 0.015 0.747 0.813 0.001 0.001 0.46 0.24
Pn-status n
Pn0 23 0.44 0.33 0.98 0.49 3.22 1.72 2.78 1.58 9.24 5.35 0.44 0.24 0.50 0.37
Pn1 10 0.23 0.14 1.11 0.13 3.66 0.80 5.01 3.35 17.73 13.32 0.37 0.33 0.40 0.28
p-value 0.032 0.717 0.951 0.001 0.002 0.981 0.278
Grading n
G1 1 - - - - - - - - - - - - - -
G2 28 0.36 0.31 1.02 0.55 3.39 1.59 2.99 1.96 9.24 8.80 0.42 0.27 0.38 0.36
G3 8 0.26 0.25 1.11 0.36 3.84 1.91 5.39 3.65 17.73 12.39 0.37 0.27 0.46 0.33
p-value 0.225 0.779 0.696 0.048 0.090 0.674 0.787
Table 1 shows the ratio of macrophage marker expression in the sinus and the interfollicular zone (IFZ) of tumor free lymph nodes in cases with different
pathohistologic classifications (T1 and T2, N0 and N+, L0 and L1, Pn0 and Pn1, G1 – G3). Values represent the median, standard deviation (SD) and
p-value (ANOVA).
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L-status. In summary, the relative ratio of M1 vs. M2
polarized macrophages showed a significant shift to-
wards M2 polarization in the LN sinus of L1 cases.Macrophage polarization and the Pn-status
Correlation of perineural infiltration status (Pn-status) of
the primary tumor with lymph node macrophage
polarization was similar to the L-status. In the LN sinus
the CD11c/CD68 ratio was significantly (p = 0.032) lower
in the Pn1 cases (median value 0.23) than in the Pn0
cases (median value 0.44) (Table 1, Figure 4a). The
CD163/CD11c resp. the MRC1/CD11c ratio was signifi-
cantly higher in the Pn1 cases with 5.01 resp. 17.73 (p =
0.001 resp. 0.002) than in the Pn0 cases (2.78 resp. 9.24)
(Table 1, Figure 4b and c).
Ratios of other parameters did not correlate with the
Pn-status. In summary, the relative ratio of M1 vs. M2
polarized macrophages showed a significant shift to-
wards M2 polarization in the LN sinus of Pn1 cases.Macrophage polarization and the grading
Macrophage polarization in tumor free regional lymph
nodes showed a correlation with the histopathological
grading of the primary tumor. High grade cases (G3)
showed a significantly (P = 0.048) increased relative M2
polarization in the LN sinus compared to intermediate
grade (G2) cases. This was shown by the median CD163/
CD11c ratio of 2.99 in the G2 and of 5.39 in the G3 cases
(Table 1, Figure 5). No other parameters correlated with
the tumor grading.
Macrophage polarization and the T-status
A correlation between the macrophage polarization in
the interfollicular zone (IFZ) of local tumor free lymph
nodes and the T-status of the primary tumor could be
shown. In contrast to L-status, Pn-status and grading,
there was no correlation of the T-status with macro-
phage polarization in the sinuses. The MRC1/CD68 ratio
in the IFZ was significantly (p = 0.027) higher in T2
cases (median value 0.60) compared to the T1 cases
(median value 0.33) (Table 1, Figure 6a). An analogous
ab
c
Figure 3 Macrophage polarization in the lymph node sinus
depending on the L-status of the primary tumor. a) The figure
shows the ratio between the CD11c cell count and the CD68 cell
count in the lymph node sinus (LN sinus) as indicator of M1
polarization. Tumor draining lymph nodes free of metastasis have
been examined. P-values generated by the ANOVA-test are
indicated. A significantly decreased CD11c/CD68 ratio in the lymph
node sinus can be found in cases with lymph vessel infiltration at
the primary tumor site (L1) compared to L0 cases. b) The
figure shows the ratio between the CD163 cell count and the CD11c
cell count in the lymph node sinus (LN sinus) as indicator of M2
polarization. Tumor draining lymph nodes free of metastasis have
been examined. P-values generated by the ANOVA-test are indicated.
A significantly increased CD163/CD11c ratio in the lymph node sinus
can be found in in cases with lymph vessel infiltration at the primary
tumor site (L1) compared to L0 cases. c) The figure shows the ratio
between the MRC1 cell count and the CD11c cell count in the lymph
node sinus (LN sinus) as indicator of M2 polarization. Tumor draining
lymph nodes free of metastasis have been examined. P-values
generated by the ANOVA-test are indicated. A significantly increased
MRC1/CD11c ratio in the lymph node sinus can be found in in cases
with lymph vessel infiltration at the primary tumor site (L1) compared
to L0 cases.
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the IFZ. This ratio was also significantly (p = 0.041) higher
comparing the T2 cases (median value 0.51) with the T1
cases (median value 0.36) (Table 1, Figure 6b). Ratios of
the other parameters did not correlate with the T-status.Macrophage polarization and the L-status in tumor free
and metastatic lymph nodes
We did not see any differences regarding the macro-
phage marker expression in tumor free and metastatic
lymph nodes. In our further analysis all regional lymph
nodes (metastatic and non metastatic) are considered as
one group. In analogy to the findings in tumor free
lymph nodes a significantly decreased CD11c/CD68 and
a significantly increased CD163/CD11c and MRC1/
CD11c ratio was detected in the L1 cases compared to
the L0 cases. Additionally significant differences in the
absolute expression of all analyzed macrophage markers
were apparent in the LN sinus.
In LN sinuses the CD68 cell count was significantly
(p = 0.027) higher (median value of 1302 cells/mm2) in the
L1 cases than in the L0 cases (median value of 1091 cells/
mm2) (Table 2, Figure 7a). An inverse relationship was ap-
parent analyzing the CD11c expression. With a median
value of 238 cells/mm2 in L1 cases compared to 423 cells/
mm2 in L0 cases the sinusoidal CD11c expression was sig-
nificantly (p = 0.032) lower (Table 2, Figure 7b).
In contrast, M2 marker expression in the LN sinus was
significantly increased in the L1 cases. CD163 resp. MRC1
expression was significantly (p = 0.002 resp. 0.035) higher
in L1 cases (1618 resp. 4493 cells/mm2) than in L0 cases
(1098 resp. 3608 cells/mm2) (Table 2, Figure 7c and d).
ab
c
Figure 4 Macrophage polarization in the lymph node sinus
depending on the Pn-status of the primary tumor. a) The figure
shows the ratio between the CD11c cell count and the CD68 cell
count in the lymph node sinus (LN sinus) as indicator of M1
polarization. Tumor draining lymph nodes free of metastasis have been
examined. P-values generated by the ANOVA-test are indicated. A
significantly decreased CD11c/CD68 ratio in the lymph node sinus can
be found in cases with perineural infiltration at the primary tumor site
(Pn1) compared to Pn0 cases. b) The figure shows the ratio between
the CD163 cell count and the CD11c cell count in the lymph node
sinus (LN sinus) as indicator of M2 polarization. Tumor draining lymph
nodes free of metastasis have been examined. P-values generated by
the ANOVA-test are indicated. A significantly increased CD163/CD11c
ratio in the lymph node sinus can be found in cases with perineural
infiltration at the primary tumor site (Pn1) compared to Pn0 cases.
c) The figure shows the ratio between the MRC1 cell count and the
CD11c cell count in the lymph node sinus (LN sinus) as indicator of M2
polarization. Tumor draining lymph nodes free of metastasis have been
examined. P-values generated by the ANOVA-test are indicated. A
significantly increased MRC1/CD11c ratio in the lymph node sinus can
be found in in cases with perineural infiltration at the primary tumor
site (Pn1) compared to Pn0 cases.
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M1 and a significantly increased M2 polarization in the
LN sinus. These correlations are apparent in the meta-
static as well as in the tumor free regional lymph nodes.
Discussion
In the present study an association of macrophage
polarization in the regional lymph nodes of oral squa-
mous cell carcinomas with parameters of malignancyFigure 5 Macrophage polarization in the lymph node sinus
depending on the grading of the primary tumor. The figure
shows the ratio between the CD163 cell count and the CD11c cell
count in the lymph node sinus (LN sinus) as indicator of M2
polarization. Tumor draining lymph nodes free of metastasis have
been examined. P-values generated by the ANOVA-test are
indicated. A significantly increased CD163/CD11c ratio in the lymph
node sinus can be found in in cases with Grading 3 (G3) of the
primary tumor compared to cases with Grading 2 (G2).
ab
Figure 6 Macrophage polarization in the lymph node
interfollicular zone depending on the T-status of the primary
tumor. a) The figure shows the ratio between the MRC1 cell count
and the CD68 cell count in the interfollicular zone of the lymph
node (LN IFZ) as indicator of M2 polarization. Tumor draining lymph
nodes free of metastasis have been examined. P-values generated
by the ANOVA-test are indicated. A significantly increased MRC1/
CD68 ratio in the lymph node sinus can be found in pT2 cases
compared to pT1 cases. b) The figure shows the ratio between the
MRC1 cell count and the CD11c cell count in the interfollicular zone
of the lymph node (LN IFZ) as indicator of M2 polarization. Tumor
draining lymph nodes free of metastasis have been examined. P-values
generated by the ANOVA-test are indicated. A significantly increased
MRC1/CD11c ratio in the lymph node sinus can be found in pT2 cases
compared to pT1 cases.
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mary tumor was noted. Markers of malignant behavior
in the primary tumor were associated with a shift of
macrophage polarization in lymph nodes from the anti-
tumoral M1 type to the tumor-promoting M2 type.
Oscc cases with lymph vessel infiltration at the primary
tumor site (L1) showed an increased M2 and a decreased
M1 polarization in the sinuses of the regional lymph nodes.
This finding might indicate that malignant cell infiltrationinto the lymph vessels leads to a shift in sinusoidal macro-
phage polarization towards the tumor-promoting M2 type.
Current literature indicates that carcinomas access the
lymphatic system by triggering lymph vessel proliferation
and invade into the lymph vessels. Thereby carcinoma
cells establish a physical connection to the local tumor
draining lymph nodes [16].
Since the lymph node sinus represents a direct con-
nection to the afferent lymph vessels, this is the anatom-
ical compartment of the lymph node with first contact
to afferent lymph. Tumor derived factors might influ-
ence the macrophage physiology in the sinus polarizing
them into a M2 state [16]. Sinusoidal M2 macrophages
might contribute to a tumor derived peripheral immune
tolerance and could facilitate metastatic growth.
In cases with perineural infiltration (Pn1) of the primary
tumor a decreased M1 and increased M2 polarization in
the lymph node sinuses was shown in our study.
According to literature lymph vessel infiltration (L1)
and perineural infiltration (Pn1) in oral cancer are asso-
ciated with the occurrence of lymph node metastasis
and indicate an inferior prognosis [45]. Histopathologic-
ally defined Pn1 is also associated with an increased risk
of local recurrence [46].
In cases with high grading (G3) we also observed a
shift towards M2 polarized macrophages in the LN si-
nuses. Literature shows that high grading is associated
with higher incidence of lymph node and distant metas-
tasis [47] and correlates with a poor prognosis of oscc
patients [47,48].
Compared to pT1 cases, pT2 cases showed a signifi-
cantly increased M2 polarization in the interfollicular
zone of the lymph nodes. Thus, increased invasiveness is
associated with augmented M2 polarization in the re-
gional lymph nodes. According to other published data,
the T-status shows a significant correlation with the
prognosis of oscc patients [44].
Combining aforementioned outcomes of our study it
can be hypothesized that increased malignant behavior of
the primary carcinoma influences the immunological situ-
ation in the draining lymph nodes. Increased invasiveness
and malignancy are associated with immune tolerance-
mediating M2 macrophages in the lymph nodes.
However, we did not find any difference regarding the
macrophage marker expression in the tumor free lymph
nodes of N0 and N + carcinomas. Therefore, it can be
hypothesized that there are no general differences con-
cerning the lymph node macrophage polarization in pa-
tients free of metastatic tumor growth compared to
patients that develop lymph node metastasis. This has to
be interpreted considering the results of our previous
study analyzing the macrophage polarization in oscc
tumor tissue [26]. A correlation of the macrophage
polarization of the primary tumor with the occurrence
Table 2 Macrophage marker expression (cells/mm2) in L0 and L1 cases (cell count in the sinus of tumor free lymph
nodes and metastatic lymph nodes)
Marker CD68 LN sinus CD11c LN sinus CD163 LN sinus MRC1 LN sinus
Median IQR SD Median IQR SD Median IQR SD Median IQR SD
L-status n
L0 37 1091 439 423 366 1098 525 3608 1755
658 299 739 2700
L1 15 1302 501 238 189 1618 539 4493 2058
686 198 793 2495
p-value 0.027 0.032 0.002 0.035
Table five shows the expression of macrophage markers in the lymph node sinus in L0 and L1 cases. Values represent the median, interquartile range (IQR),





Figure 7 Macrophage cell count (cells/mm2) in tumor free and metastatic lymph nodes depending on the L-status of the primary
tumor. The figure shows the median macrophage cell count (cells/mm2 specimen area) in the lymph node sinus (LN sinus) depending on the
lymph vessel infiltration status of the primary tumor (L0 vs. L1). Both groups of tumor draining lymph nodes have been examined (lymph nodes
free of metastasis and metastatic lymph nodes). P-values generated by the ANOVA-test are indicated. a) CD68 cell count: A significantly increased
count can be observed in the L1 cases. b) CD11c cell count: A significantly decreased count can be observed in the L1 cases. c) CD163 cell count:
A significantly increased count can be observed in the L1 cases. d) MRC1 cell count: A significantly increased count can be observed in the L1 cases.
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the previous results in conjunction with the results of
the current study it can be concluded that the formation
of metastases is triggered by the primary tumor and not
by the lymph nodes.
Additionally we did not find a difference in macrophage
marker expression in tumor free and metastatic lymph
nodes. According to this observation, the presence or ab-
sence of metastatic tumor growth in lymph nodes seems
not to influence local macrophage polarization. This ini-
tially astonishing finding is in accordance with other pub-
lished data [14]. In melanoma patients it could be shown
that tumor derived changes in the lymph node immune
milieu are independent of the existence of lymph node
metastases [14]. T-cell polarization and several immune
tolerance markers did not differ between metastatic senti-
nel lymph nodes and tumor free nodes [49]. However,
there are immunological alterations in tumor-associated
lymph nodes that prepare them for the acceptance of
tumor cells and are a prerequisite for metastatic tumor
growth [14,49]. Our data indicate that there might be a
similar situation in oral cancer.
The fact that we did not detect a different immune re-
activity in tumor free and metastatic lymph nodes also
suggests that the tumor causes systemic or at least loco-
regionally homogeneous immune tolerance. This finding
is analogous to 30 year old studies analyzing the PHA-
reactivity in the serum of oscc patients that already indi-
cated a systemic tumor derived immune suppression [8,9].
In addition, the role of the immune system in oscc
progression is underlined by the results of a recent study
investigating parameters influencing the prognosis of
HPV positive oral cancer [28]. The prognosis of HPV
positive cases with low levels of tumor infiltrating lym-
phocytes (TIL) did not differ from HPV negative cases.
Whereas, the HPV infected cases with high TIL-levels
showed the commonly described superior survival [28].
The HPV infected tumor cells seem to be targets for im-
mune cells and fail to establish a tumor derived immune
tolerance. This finding can be understood as a general
principle: The prognosis of tumors seems to correlate
with the ability of the host defense to target the cancer
cells.
It needs to be considered that the markers (CD68,
CD11c, CD163 and MRC1) used in this study are not
completely macrophage specific. E.g. CD68 is also
expressed by fibroblasts and also by some cancer cells
[50]. Besides macrophages, CD11c is also expressed by
some types of dendritic cells. We tried to overcome this
problem as far as possible by counting only cells with a
macrophage-like morphology. This was supervised by a
pathologist.
The results of the present study also indicate the im-
portance of spatial resolution in the investigation ofmacrophage polarization in lymph nodes. The benefit of
the complete digitalization and virtual microscope sys-
tems performed in this study was the ability to exactly
mark the different lymph node compartments on all an-
alyzed fields of view and to perform a separate cell
counting. Analog studies in other types of carcinoma
would be desirable to validate the hypothesis that im-
paired lymph node macrophage polarization is a general
principle of tumor progression or special to oral squa-
mous cell carcinomas.
The association of criteria of increased malignancy
and invasiveness of the primary tumor and lymph node
M2 polarization might be an expression of a tumor de-
rived peripheral immune tolerance, facilitating further
tumor progression.
A therapeutic approach targeting macrophage polarization
could be the application of bisphosphonates. Recent
studies have shown a beneficial effect of bisphospho-
nates in early stage breast cancer lacking bone metastasis
[51,52]. A possible explanation for this clinical observation
could be the recently discovered capability of bisphospho-
nates to repolarize macrophages from a tumor promoting
M2 phenotype to an anti-tumoral M1 phenotype [53]. In
a mouse model it could be shown that clinically achievable
doses of the bisphosphonate zoledronic acid repolarized
tumor associated macrophages towards a full M1 activa-
tion state [54]. These data indicate the potential of
bisphosphonates to directly target tumor associated
macrophages [54].
Conclusions
Concluding, we can propose the hypothesis that the
tumor influences the milieu in the regional lymph nodes
and prepares them for the acceptance of metastatic
growth by establishing a state of peripheral immune toler-
ance. However, the decision if the primary tumor estab-
lishes metastatic lesions is not made in the lymph nodes,
but in the primary tumor.
These considerations should encourage further research
analyzing the underlying mechanisms of tumor derived and
macrophage mediated peripheral immune tolerance. Break-
ing immune tolerance – e.g. by using bisphosphonates –
would open new perspectives in viral cancer therapy and
cancer vaccination strategies, expanding our current treat-
ment options.
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